Shingles, commonly known as herpes
zoster, is a viral infection that attacks the cranial nerves that originate in
the brain. It's caused by the varicella zoster virus, which is also responsible
for chicken pox. Because the virus can remain dormant in the human body for
several years, everyone who has had chicken pox before is at risk of acquiring
shingles. According to the Centers for Disease Control and Prevention (CDC),
one million cases of shingles were reported in the United States in 2018.
Furthermore, the CDC estimates that one out of every three persons in the
United States will have shingles at some point in their lives. The risk of
shingles increases with age, with the majority of occurrences occurring in
adults over the age of 40. This is primarily due to a weakened immune system as
a result of increased stress and insufficient consumption of vital nutrients to
maintain immunity.
Global Shingles Vaccine Market Dynamics
Merck & Co., Inc. licenced the
Zostavax vaccine in 2006, and it is an effective shingles vaccine. The vaccine
is indicated for those who are 50 years old or older. The Zostavax vaccination
was found to be 64% effective in adults aged 60 to 69 years old in clinical
studies. As people get older, their effectiveness decreases, dropping to 41%
for those aged 70–79 and 18% for those aged 80 and up. In February 2016, the
vaccine was introduced in India at half the price of the US market. In 2015,
Zostavax was the sole shingles
vaccine market, with sales of $749 million.
Global Shingles Vaccine Market Regional
Analysis
Between 2016 and 2024, North America
and Europe are estimated to account for the majority of the market. The market
in North America is likely to rise because to rising demand in the United
States, while the market in Europe is expected to grow due to increased
therapeutic demand from the European Union.
Over the projected period, the Asia
Pacific shingles vaccine market is expected to develop at the fastest rate. In
the region, particularly in China and India, there is a large potential market
that has to be exploited. Companies would benefit from active marketing and
differential pricing to strengthen their market position in Asia Pacific.
Comments
Post a Comment